F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Everolimus

Page 1 of 1 ( 25 items )
<<
1
>>

1	Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature 10/21/2022 2:24:59 AM \| Browse: 324 \| Download: 787
2	Current aspects of renal dysfunction after liver transplantation 1/21/2022 8:16:14 AM \| Browse: 467 \| Download: 1036
3	Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report 5/20/2021 3:14:20 PM \| Browse: 496 \| Download: 1174
4	Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario 12/17/2020 9:42:32 AM \| Browse: 635 \| Download: 1399
5	Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 12/21/2018 1:32:15 AM \| Browse: 881 \| Download: 1028
6	Introduction of everolimus in kidney transplant recipients at a late posttransplant stage 9/7/2018 6:15:25 AM \| Browse: 899 \| Download: 1467
7	Use of everolimus in liver transplantation 8/18/2017 1:45:25 AM \| Browse: 1049 \| Download: 1221
8	Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation 6/20/2017 12:12:53 PM \| Browse: 926 \| Download: 1559
9	Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate 4/7/2017 8:24:12 AM \| Browse: 1055 \| Download: 1329
10	Growth hormone abolishes the negative effects of everolimus on intestinal wound healing 4/29/2016 4:50:00 PM \| Browse: 1387 \| Download: 2248
11	Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale? 4/7/2016 11:01:00 AM \| Browse: 1099 \| Download: 1745
12	Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 3/30/2016 2:15:00 PM \| Browse: 1044 \| Download: 1596
13	Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis 3/21/2016 8:54:00 AM \| Browse: 1047 \| Download: 1435
14	Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation 3/18/2016 2:28:00 PM \| Browse: 1202 \| Download: 1778
15	Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients 12/23/2015 8:26:00 AM \| Browse: 1138 \| Download: 2000
16	Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful 12/23/2015 8:26:00 AM \| Browse: 991 \| Download: 2283
17	Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center 12/23/2015 8:26:00 AM \| Browse: 1361 \| Download: 2811
18	Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic 12/9/2015 6:37:00 PM \| Browse: 1050 \| Download: 1587
19	Mammalian target of rapamycin inhibition in hepatocellular carcinoma 12/2/2015 12:16:00 PM \| Browse: 1182 \| Download: 1360
20	Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges 4/19/2015 5:46:00 PM \| Browse: 1207 \| Download: 1665
21	Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions 12/11/2014 2:06:00 PM \| Browse: 1129 \| Download: 1353
22	Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors 11/17/2014 3:13:00 PM \| Browse: 1019 \| Download: 1333
23	Hepatitis B reactivation related to everolimus 9/10/2014 3:18:00 PM \| Browse: 1016 \| Download: 603
24	Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients 8/25/2014 9:54:00 AM \| Browse: 952 \| Download: 1147
25	Multiple indications for everolimus after liver transplantation in current clinical practice 8/25/2014 9:54:00 AM \| Browse: 1005 \| Download: 994

Page 1 of 1 ( 25 items )
<<
1
>>

1	Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature 10/21/2022 2:24:59 AM \| Browse: 324 \| Download: 787
2	Current aspects of renal dysfunction after liver transplantation 1/21/2022 8:16:14 AM \| Browse: 467 \| Download: 1036
3	Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report 5/20/2021 3:14:20 PM \| Browse: 496 \| Download: 1174
4	Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario 12/17/2020 9:42:32 AM \| Browse: 635 \| Download: 1399
5	Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 12/21/2018 1:32:15 AM \| Browse: 881 \| Download: 1028
6	Introduction of everolimus in kidney transplant recipients at a late posttransplant stage 9/7/2018 6:15:25 AM \| Browse: 899 \| Download: 1467
7	Use of everolimus in liver transplantation 8/18/2017 1:45:25 AM \| Browse: 1049 \| Download: 1221
8	Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation 6/20/2017 12:12:53 PM \| Browse: 926 \| Download: 1559
9	Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate 4/7/2017 8:24:12 AM \| Browse: 1055 \| Download: 1329
10	Growth hormone abolishes the negative effects of everolimus on intestinal wound healing 4/29/2016 4:50:00 PM \| Browse: 1387 \| Download: 2248
11	Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale? 4/7/2016 11:01:00 AM \| Browse: 1099 \| Download: 1745
12	Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 3/30/2016 2:15:00 PM \| Browse: 1044 \| Download: 1596
13	Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis 3/21/2016 8:54:00 AM \| Browse: 1047 \| Download: 1435
14	Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation 3/18/2016 2:28:00 PM \| Browse: 1202 \| Download: 1778
15	Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients 12/23/2015 8:26:00 AM \| Browse: 1138 \| Download: 2000
16	Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful 12/23/2015 8:26:00 AM \| Browse: 991 \| Download: 2283
17	Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center 12/23/2015 8:26:00 AM \| Browse: 1361 \| Download: 2811
18	Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic 12/9/2015 6:37:00 PM \| Browse: 1050 \| Download: 1587
19	Mammalian target of rapamycin inhibition in hepatocellular carcinoma 12/2/2015 12:16:00 PM \| Browse: 1182 \| Download: 1360
20	Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges 4/19/2015 5:46:00 PM \| Browse: 1207 \| Download: 1665
21	Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions 12/11/2014 2:06:00 PM \| Browse: 1129 \| Download: 1353
22	Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors 11/17/2014 3:13:00 PM \| Browse: 1019 \| Download: 1333
23	Hepatitis B reactivation related to everolimus 9/10/2014 3:18:00 PM \| Browse: 1016 \| Download: 603
24	Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients 8/25/2014 9:54:00 AM \| Browse: 952 \| Download: 1147
25	Multiple indications for everolimus after liver transplantation in current clinical practice 8/25/2014 9:54:00 AM \| Browse: 1005 \| Download: 994